Necroptosis was activated in NAFLD, leading to more severe IRI, and such necroptosis could be inhibited by TN3-19.12, the neutralizing monoclonal antibody against TNFα. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.